Phillips Edison & Co Inc
F:9R4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Phillips Edison & Co Inc
F:9R4
|
US |
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
G
|
Genfit SA
F:XUPB
|
FR |
|
K
|
Kandenko Co Ltd
F:5EY
|
JP |
|
Sarana Meditama Metropolitan Tbk PT
IDX:SAME
|
ID |
|
A
|
Anheuser Busch Inbev SA
F:ITKA
|
BE |
|
B
|
BETA Technologies Inc
NYSE:BETA
|
US |
|
XBiotech Inc
NASDAQ:XBIT
|
US |
|
U
|
UFP Technologies Inc
XMUN:UFP
|
US |
|
L
|
Leggett & Platt Inc
XBER:LP1
|
US |
|
Broadcom Inc
SIX:AVGO
|
US |
|
F
|
Fraport Frankfurt Airport Services Worldwide AG
XMUN:FRA
|
DE |
|
A
|
Alarm.com Holdings Inc
XBER:3RL
|
US |
|
T
|
Trimble Inc
XMUN:TB5
|
US |
Wall St Price Targets
9R4 Price Targets Summary
Phillips Edison & Co Inc
According to Wall Street analysts, the average 1-year price target for 9R4 is 36.16 EUR with a low forecast of 32.33 EUR and a high forecast of 39.8 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9R4's stock price target?
Price Target
36.16
EUR
According to Wall Street analysts, the average 1-year price target for 9R4 is 36.16 EUR with a low forecast of 32.33 EUR and a high forecast of 39.8 EUR.
What is the Revenue forecast for Phillips Edison & Co Inc?
Projected CAGR
4%
Over the last 12 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Phillips Edison & Co Inc?
Projected CAGR
14%
Over the last 12 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Phillips Edison & Co Inc?
Projected CAGR
5%
The compound annual growth rate for Net Income over the next 3 years is 5%.
